EMB vs MEDAX: Yield, Cost and Returns Compared
As of Nov 17, 2026, MEDAX yields more: 5.68% (dividend yield) against 5.42% for EMB. EMB is cheaper to own at 0.39% a year vs 1.07%. Over the same 18 years (Dec 2007 to Oct 2026), MEDAX returned 4.8% a year with distributions reinvested, and EMB 4.4%.
| Compared | EMB | MEDAX |
|---|---|---|
| YieldDividend yield | 5.42% | 5.68% |
| Expense ratio | 0.39% | 1.07% |
| Total return, 1 yr | +0.3% | +1.6% |
| Total return, 3 yr (a year) | +9.9% | +10.0% |
| Total return, 5 yr (a year) | +1.5% | +2.2% |
| Total return, 10 yr (a year) | +2.6% | +3.1% |
| Worst drop since Dec 2007 | -26.7% | -24.3% |
| Share price since Dec 2007 | −9% | −12% |
| Pays | Monthly | Monthly |
| Issuer | iShares | MFS |
| Assets | $13.6B | $7.0B |
| Started | 2007 | 2008 |
| Type | Emerging Markets Bond | Emerging Markets Bond |
Higher yield
MEDAX
5.68%
Lower cost
EMB
0.39%
Better total return
MEDAX
4.8%/yr
Smaller worst drop
MEDAX
-24.3%
Key facts: EMB vs MEDAX
Data as of · Source: SmarterDividends data
- As of Nov 17, 2026, EMB yields 5.42% (dividend yield) and MEDAX yields 5.68% (dividend yield).
- EMB's expense ratio is 0.39% and MEDAX's is 1.07%: $39 vs $107 a year on $10,000.
- From Dec 2007 to Oct 2026, $10,000 in EMB grew to $22,697 (4.4% a year) and $10,000 in MEDAX to $23,999 (4.8% a year), distributions reinvested.
- Their worst month-end drops over that time: -26.7% for EMB and -24.3% for MEDAX.
- 0 of EMB's top ten holdings are also in MEDAX's top ten.
Cite this page
SmarterDividends, "EMB vs MEDAX: Yield, Cost and Returns Compared," updated Nov 17, 2026, https://smarterdividends.com/compare/emb-vs-medax
$10,000 in each, Dec 2007 to Oct 2026
Distributions reinvested, month-end values, with the S&P 500 for reference.
EMB became
$22,697
4.4% a year
MEDAX became
$23,999
4.8% a year
Year by year
| Year | EMB | MEDAX |
|---|---|---|
| 2025 | +13.9% | +12.3% |
| 2024 | +5.5% | +6.8% |
| 2023 | +10.6% | +10.2% |
| 2022 | −18.6% | −15.0% |
| 2021 | −2.2% | −2.6% |
| 2020 | +5.4% | +7.7% |
| 2019 | +15.5% | +13.8% |
| 2018 | −5.5% | −5.2% |
| 2017 | +10.3% | +9.3% |
| 2016 | +9.3% | +9.2% |
| 2015 | +1.0% | −0.8% |
| 2014 | +6.1% | +4.4% |
| 2013 | −7.8% | −6.4% |
| 2012 | +16.9% | +18.9% |
| 2011 | +7.7% | +5.9% |
| 2010 | +10.8% | +10.9% |
| 2009 | +15.4% | +30.9% |
| 2008 | −2.1% | −10.9% |
Total return each calendar year, distributions reinvested.
Top holdings
No overlap in the top ten.
EMB
- XTSLA BlackRock Cash Funds Treasury SL Agency0.5%
MEDAX
- Euro Bund Future Dec 265.3%
EMB vs MEDAX: questions
Is EMB or MEDAX better?
It depends on the job. MEDAX pays more today (5.68% vs 5.42%), EMB costs less, and MEDAX has the better total return over Dec 2007 to Oct 2026, with MEDAX holding up better in its worst stretch. For income, look at yield and whether the payouts hold up; for growth, total return and drawdowns.
Which pays a higher dividend, EMB or MEDAX?
MEDAX, at 5.68% against 5.42% for EMB as of Nov 17, 2026. On $10,000 that's about $568 vs $542 a year at today's rates.
Which has the better total return?
MEDAX. From Dec 2007 to Oct 2026, it returned 4.8% a year with distributions reinvested, against 4.4% for EMB. $10,000 became $23,999 vs $22,697.
Which is cheaper, EMB or MEDAX?
EMB, with a 0.39% expense ratio against 1.07%.
Do EMB and MEDAX hold the same things?
Not at the top: none of their top ten holdings match.
Yields, costs and holdings as each fund reports them (via Yahoo Finance), updated daily; returns from month-end prices with distributions reinvested. MEDAX leads on 6 of 8 measures above. For information only, not investment advice. Last fund data: Nov 17, 2026.
